1. Home
  2. DNLI vs VSH Comparison

DNLI vs VSH Comparison

Compare DNLI & VSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • VSH
  • Stock Information
  • Founded
  • DNLI 2013
  • VSH 1962
  • Country
  • DNLI United States
  • VSH United States
  • Employees
  • DNLI N/A
  • VSH N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • VSH Electrical Products
  • Sector
  • DNLI Health Care
  • VSH Technology
  • Exchange
  • DNLI Nasdaq
  • VSH Nasdaq
  • Market Cap
  • DNLI 1.9B
  • VSH 1.9B
  • IPO Year
  • DNLI 2017
  • VSH N/A
  • Fundamental
  • Price
  • DNLI $13.21
  • VSH $13.91
  • Analyst Decision
  • DNLI Strong Buy
  • VSH Hold
  • Analyst Count
  • DNLI 15
  • VSH 2
  • Target Price
  • DNLI $33.85
  • VSH $20.50
  • AVG Volume (30 Days)
  • DNLI 1.3M
  • VSH 1.8M
  • Earning Date
  • DNLI 05-06-2025
  • VSH 05-07-2025
  • Dividend Yield
  • DNLI N/A
  • VSH 2.84%
  • EPS Growth
  • DNLI N/A
  • VSH N/A
  • EPS
  • DNLI N/A
  • VSH N/A
  • Revenue
  • DNLI N/A
  • VSH $2,906,544,000.00
  • Revenue This Year
  • DNLI N/A
  • VSH $4.10
  • Revenue Next Year
  • DNLI $256.73
  • VSH $6.15
  • P/E Ratio
  • DNLI N/A
  • VSH N/A
  • Revenue Growth
  • DNLI N/A
  • VSH N/A
  • 52 Week Low
  • DNLI $10.57
  • VSH $10.35
  • 52 Week High
  • DNLI $33.33
  • VSH $24.69
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 44.46
  • VSH 48.05
  • Support Level
  • DNLI $12.86
  • VSH $13.60
  • Resistance Level
  • DNLI $13.77
  • VSH $14.58
  • Average True Range (ATR)
  • DNLI 0.72
  • VSH 0.41
  • MACD
  • DNLI -0.08
  • VSH -0.07
  • Stochastic Oscillator
  • DNLI 32.29
  • VSH 13.71

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About VSH Vishay Intertechnology Inc.

Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer all over the world. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.

Share on Social Networks: